| DBVT |
DBV Technologies S.A. |
12 Jan 2026 |
4 |
$0 |
4 |
Director |
14 Jan 2026, 16:33 |
| BCYC |
BICYCLE THERAPEUTICS PLC |
02 Jan 2026 |
4 |
$0 |
4 |
Director, 10%+ Owner |
06 Jan 2026, 17:41 |
| INCY |
INCYTE CORP |
31 Dec 2025 |
2 |
$0 |
4 |
Director, 10%+ Owner |
05 Jan 2026, 16:02 |
| KOD |
Kodiak Sciences Inc. |
18 Dec 2025 |
2 |
+$60,000,008 |
4 |
Director, 10%+ Owner |
19 Dec 2025, 16:06 |
| DNLI |
Denali Therapeutics Inc. |
11 Dec 2025 |
2 |
+$39,977,138 |
4 |
Director |
15 Dec 2025, 16:33 |
| KYMR |
Kymera Therapeutics, Inc. |
11 Dec 2025 |
2 |
+$172,499,918 |
4 |
Director, 10%+ Owner |
11 Dec 2025, 16:19 |
| TRDA |
Entrada Therapeutics, Inc. |
20 Nov 2025 |
4 |
+$261,846 |
4 |
10%+ Owner |
24 Nov 2025, 16:09 |
| TRDA |
Entrada Therapeutics, Inc. |
10 Nov 2025 |
12 |
+$1,352,587 |
4 |
10%+ Owner |
12 Nov 2025, 17:34 |
| KALA |
KALA BIO, Inc. |
30 Sep 2025 |
4 |
-$1,056,722 |
4 |
Former 10% owner |
02 Oct 2025, 16:47 |
| INCY |
INCYTE CORP |
30 Sep 2025 |
2 |
$0 |
4 |
Director, 10%+ Owner |
02 Oct 2025, 16:36 |
| CELC |
Celcuity Inc. |
08 Sep 2025 |
4 |
+$9,571,319 |
4 |
10%+ Owner |
10 Sep 2025, 16:06 |
| VTVT |
vTv Therapeutics Inc. |
03 Sep 2025 |
6 |
$0 |
4 |
Director |
05 Sep 2025, 16:15 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
18 Aug 2025 |
26 |
+$36,941,197 |
4 |
Director |
20 Aug 2025, 18:12 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
18 Aug 2025 |
28 |
+$24,979,827 |
4 |
Director |
20 Aug 2025, 18:09 |
| IGMS |
IGM Biosciences, Inc. |
14 Aug 2025 |
4 |
$0 |
4 |
Former 10% owner and director |
18 Aug 2025, 17:39 |
| CELC |
Celcuity Inc. |
01 Aug 2025 |
0 |
$0 |
3 |
10%+ Owner |
01 Aug 2025, 17:46 |
| IGMS |
IGM Biosciences, Inc. |
30 Jun 2025 |
2 |
$0 |
4 |
Director, 10%+ Owner |
02 Jul 2025, 17:26 |
| INCY |
INCYTE CORP |
30 Jun 2025 |
2 |
$0 |
4 |
Director, 10%+ Owner |
02 Jul 2025, 17:23 |
| TCRX |
TScan Therapeutics, Inc. |
30 Jun 2025 |
2 |
$0 |
4 |
Director |
02 Jul 2025, 17:20 |
| KOD |
Kodiak Sciences Inc. |
30 Jun 2025 |
2 |
$0 |
4 |
Director, 10%+ Owner |
02 Jul 2025, 17:08 |
| KYMR |
Kymera Therapeutics, Inc. |
30 Jun 2025 |
4 |
+$57,683,934 |
4 |
Director |
30 Jun 2025, 20:15 |
| KYMR |
Kymera Therapeutics, Inc. |
25 Jun 2025 |
2 |
$0 |
4 |
Director |
26 Jun 2025, 21:00 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
20 Jun 2025 |
4 |
$0 |
4 |
Director |
24 Jun 2025, 16:38 |
| PRLD |
Prelude Therapeutics Inc |
12 Jun 2025 |
2 |
$0 |
4 |
Director, 10%+ Owner |
13 Jun 2025, 16:45 |
| INCY |
INCYTE CORP |
10 Jun 2025 |
4 |
$0 |
4 |
Director, 10%+ Owner |
12 Jun 2025, 16:29 |
| VTVT |
vTv Therapeutics Inc. |
10 Jun 2025 |
2 |
$0 |
4 |
Director |
12 Jun 2025, 16:28 |
| KNSA |
Kiniksa Pharmaceuticals International, plc |
03 Jun 2025 |
4 |
$0 |
4 |
Director |
05 Jun 2025, 17:06 |
| DNLI |
Denali Therapeutics Inc. |
03 Jun 2025 |
4 |
$0 |
4 |
Director |
05 Jun 2025, 17:02 |
| DNLI |
Denali Therapeutics Inc. |
03 Jun 2025 |
0 |
$0 |
3 |
Director |
05 Jun 2025, 16:57 |
| ACAD |
ACADIA PHARMACEUTICALS INC |
29 May 2025 |
4 |
$0 |
4 |
Director, 10%+ Owner |
02 Jun 2025, 16:01 |
| ONC |
BeiGene, Ltd. |
21 May 2025 |
4 |
$0 |
4 |
Director |
22 May 2025, 16:10 |
| IMCR |
Immunocore Holdings plc |
15 May 2025 |
2 |
$0 |
4 |
Director |
19 May 2025, 16:04 |
| IGMS |
IGM Biosciences, Inc. |
31 Mar 2025 |
2 |
$0 |
4 |
Director, 10%+ Owner |
02 Apr 2025, 16:43 |
| INCY |
INCYTE CORP |
31 Mar 2025 |
2 |
$0 |
4 |
Director, 10%+ Owner |
02 Apr 2025, 16:39 |
| DBVT |
DBV Technologies S.A. |
27 Mar 2025 |
4 |
$0 |
4 |
Director, 10%+ Owner |
31 Mar 2025, 18:56 |
| IMCR |
Immunocore Holdings plc |
17 Mar 2025 |
6 |
-$126,006,776 |
4 |
Director |
19 Mar 2025, 18:40 |
| REPL |
Replimune Group, Inc. |
05 Mar 2025 |
2 |
$0 |
4 |
Director, 10%+ Owner |
07 Mar 2025, 16:55 |
| REPL |
Replimune Group, Inc. |
05 Mar 2025 |
0 |
$0 |
3 |
Director, 10%+ Owner |
07 Mar 2025, 16:52 |
| ONC |
BeiGene, Ltd. |
28 Feb 2025 |
2 |
-$190,535,020 |
4 |
Director |
28 Feb 2025, 21:28 |
| SERA |
SERA PROGNOSTICS, INC. |
12 Feb 2025 |
0 |
$0 |
3 |
10%+ Owner |
14 Feb 2025, 16:06 |
| BCYC |
BICYCLE THERAPEUTICS PLC |
02 Jan 2025 |
4 |
$0 |
4 |
Director, 10%+ Owner |
06 Jan 2025, 18:12 |
| IGMS |
IGM Biosciences, Inc. |
31 Dec 2024 |
2 |
$0 |
4 |
Director, 10%+ Owner |
03 Jan 2025, 17:22 |
| INCY |
INCYTE CORP |
31 Dec 2024 |
2 |
$0 |
4 |
Director, 10%+ Owner |
03 Jan 2025, 17:19 |
| KALA |
KALA BIO, Inc. |
30 Dec 2024 |
2 |
+$2,000,000 |
4 |
10%+ Owner |
31 Dec 2024, 16:00 |
| BCYC |
BICYCLE THERAPEUTICS PLC |
13 Dec 2024 |
10 |
+$21,230,385 |
4 |
Director, 10%+ Owner |
17 Dec 2024, 18:03 |
| ONC |
BeiGene, Ltd. |
09 Dec 2024 |
4 |
-$194,200,043 |
4 |
Director |
10 Dec 2024, 21:25 |
| KNSA |
Kiniksa Pharmaceuticals International, plc |
04 Oct 2024 |
4 |
$0 |
4 |
Director |
08 Oct 2024, 16:14 |
| IGMS |
IGM Biosciences, Inc. |
30 Sep 2024 |
2 |
$0 |
4 |
Director, 10%+ Owner |
02 Oct 2024, 16:14 |
| INCY |
INCYTE CORP |
30 Sep 2024 |
2 |
$0 |
4 |
Director, 10%+ Owner |
02 Oct 2024, 16:11 |
| KYMR |
Kymera Therapeutics, Inc. |
20 Aug 2024 |
3 |
+$105,711,766 |
4 |
Director |
22 Aug 2024, 16:03 |
| IGMS |
IGM Biosciences, Inc. |
28 Jun 2024 |
2 |
$0 |
4 |
Director, 10%+ Owner |
02 Jul 2024, 17:04 |
| INCY |
INCYTE CORP |
28 Jun 2024 |
2 |
$0 |
4 |
Director, 10%+ Owner |
02 Jul 2024, 16:54 |
| KOD |
Kodiak Sciences Inc. |
28 Jun 2024 |
2 |
$0 |
4 |
Director, 10%+ Owner |
02 Jul 2024, 16:49 |
| KALA |
KALA BIO, Inc. |
28 Jun 2024 |
0 |
$0 |
3 |
10%+ Owner |
28 Jun 2024, 16:03 |
| VTVT |
vTv Therapeutics Inc. |
25 Jun 2024 |
4 |
$0 |
4 |
Director |
27 Jun 2024, 17:39 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
25 Jun 2024 |
4 |
$0 |
4 |
Director |
27 Jun 2024, 17:03 |
| TRDA |
Entrada Therapeutics, Inc. |
25 Jun 2024 |
2 |
+$49,999,658 |
4 |
10%+ Owner |
26 Jun 2024, 16:53 |
| BCYC |
BICYCLE THERAPEUTICS PLC |
17 Jun 2024 |
4 |
$0 |
4 |
Director, 10%+ Owner |
20 Jun 2024, 16:05 |
| PRLD |
Prelude Therapeutics Inc |
14 Jun 2024 |
2 |
$0 |
4 |
Director, 10%+ Owner |
18 Jun 2024, 16:26 |
| INCY |
INCYTE CORP |
12 Jun 2024 |
6 |
-$327,550,980 |
4 |
Director, 10%+ Owner |
14 Jun 2024, 16:15 |
| TCRX |
TScan Therapeutics, Inc. |
12 Jun 2024 |
2 |
$0 |
4 |
Director |
14 Jun 2024, 16:13 |
| KNSA |
Kiniksa Pharmaceuticals, Ltd. |
05 Jun 2024 |
4 |
$0 |
4 |
Director |
07 Jun 2024, 16:07 |
| ONC |
BeiGene, Ltd. |
05 Jun 2024 |
4 |
$0 |
4 |
Director, 10%+ Owner |
07 Jun 2024, 16:03 |
| ACAD |
ACADIA PHARMACEUTICALS INC |
29 May 2024 |
4 |
$0 |
4 |
Director, 10%+ Owner |
31 May 2024, 16:10 |
| BCYC |
BICYCLE THERAPEUTICS plc |
29 May 2024 |
2 |
+$366,600,001 |
4 |
Director, 10%+ Owner |
29 May 2024, 16:22 |
| IMCR |
Immunocore Holdings plc |
28 May 2024 |
2 |
$0 |
4 |
Director |
29 May 2024, 16:53 |
| IMCR |
Immunocore Holdings plc |
28 May 2024 |
0 |
$0 |
3 |
Director |
29 May 2024, 16:43 |
| INCY |
INCYTE CORP |
07 May 2024 |
4 |
+$1,470,300 |
4 |
Director, 10%+ Owner |
09 May 2024, 18:25 |
| TCRX |
TScan Therapeutics, Inc. |
19 Apr 2024 |
2 |
+$68,999,030 |
4 |
Director |
23 Apr 2024, 16:17 |
| BCYC |
BICYCLE THERAPEUTICS plc |
18 Apr 2024 |
4 |
$0 |
4 |
Director, 10%+ Owner |
22 Apr 2024, 16:03 |
| BCYC |
BICYCLE THERAPEUTICS plc |
18 Apr 2024 |
0 |
$0 |
3 |
Director, 10%+ Owner |
18 Apr 2024, 07:26 |
| IGMS |
IGM Biosciences, Inc. |
29 Mar 2024 |
2 |
$0 |
4 |
Director, 10%+ Owner |
01 Apr 2024, 16:22 |
| INCY |
INCYTE CORP |
28 Mar 2024 |
2 |
$0 |
4 |
Director, 10%+ Owner |
01 Apr 2024, 16:26 |
| KYMR |
Kymera Therapeutics, Inc. |
28 Mar 2024 |
2 |
$0 |
4 |
Director |
01 Apr 2024, 08:56 |
| KYMR |
Kymera Therapeutics, Inc. |
28 Mar 2024 |
0 |
$0 |
3 |
Director |
01 Apr 2024, 08:53 |
| IGMS |
IGM Biosciences, Inc. |
26 Mar 2024 |
8 |
+$3,425,569 |
4 |
Director, 10%+ Owner |
28 Mar 2024, 19:04 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
21 Mar 2024 |
2 |
+$274,999,814 |
4 |
Director |
25 Mar 2024, 16:21 |
| IGMS |
IGM Biosciences, Inc. |
12 Mar 2024 |
2 |
$0 |
4 |
Director, 10%+ Owner |
14 Mar 2024, 16:36 |
| VTVT |
vTv Therapeutics Inc. |
05 Mar 2024 |
4 |
$0 |
4 |
Director |
07 Mar 2024, 16:53 |
| VTVT |
vTv Therapeutics Inc. |
27 Feb 2024 |
0 |
$0 |
3 |
Director |
07 Mar 2024, 16:50 |
| IGMS |
IGM Biosciences, Inc. |
29 Dec 2023 |
2 |
$0 |
4 |
Director, 10%+ Owner |
03 Jan 2024, 18:02 |
| INCY |
INCYTE CORP |
29 Dec 2023 |
2 |
$0 |
4 |
Director, 10%+ Owner |
03 Jan 2024, 17:58 |
| NGNE |
Neurogene Inc. |
18 Dec 2023 |
8 |
$0 |
4 |
Director, Former 10% Owner |
20 Dec 2023, 18:43 |
| /report/000120919123059034-baker-bros-advisors-lp-2023-12-14 |
Seagen Inc. |
14 Dec 2023 |
13 |
-$10,248,908,740 |
4 |
Director, Former 10% Owner |
18 Dec 2023, 18:46 |
| IGMS |
IGM Biosciences, Inc. |
13 Dec 2023 |
12 |
+$3,431,464 |
4 |
Director, 10%+ Owner |
15 Dec 2023, 17:32 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
13 Dec 2023 |
24 |
+$22,516,577 |
4 |
Director |
14 Dec 2023, 18:10 |
| PRLD |
Prelude Therapeutics Inc |
13 Dec 2023 |
2 |
+$24,999,997 |
4 |
Director, 10%+ Owner |
13 Dec 2023, 16:35 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
12 Dec 2023 |
30 |
+$7,548,616 |
4 |
Director |
14 Dec 2023, 18:09 |
| /report/000120919123056578-baker-bros-advisors-lp-2023-11-22 |
BELLICUM PHARMACEUTICALS, INC |
22 Nov 2023 |
4 |
+$212 |
4 |
10%+ Owner |
24 Nov 2023, 13:39 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
21 Nov 2023 |
20 |
+$12,128,340 |
4 |
Director |
21 Nov 2023, 18:15 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
17 Nov 2023 |
30 |
+$11,947,280 |
4 |
Director |
21 Nov 2023, 18:14 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
14 Nov 2023 |
4 |
+$7,809,559 |
4 |
Director |
15 Nov 2023, 17:13 |
| ONC |
BeiGene, Ltd. |
14 Nov 2023 |
2 |
-$198,550,000 |
4 |
Director, 10%+ Owner |
14 Nov 2023, 17:54 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
13 Nov 2023 |
30 |
+$15,801,021 |
4 |
Director |
15 Nov 2023, 17:12 |
| /report/000120919123053345-baker-bros-advisors-lp-2023-10-19 |
Atreca, Inc. |
19 Oct 2023 |
2 |
-$110,582 |
4 |
Former 10% Owner |
23 Oct 2023, 16:49 |
| NGNE |
Neoleukin Therapeutics, Inc. |
05 Oct 2023 |
4 |
$0 |
4 |
Director, 10%+ Owner |
10 Oct 2023, 16:22 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
03 Oct 2023 |
2 |
+$249,999,821 |
4 |
Director |
05 Oct 2023, 16:27 |
| IGMS |
IGM Biosciences, Inc. |
29 Sep 2023 |
2 |
$0 |
4 |
Director |
03 Oct 2023, 17:33 |
| INCY |
INCYTE CORP |
29 Sep 2023 |
2 |
$0 |
4 |
Director, 10%+ Owner |
03 Oct 2023, 17:32 |
| NGNE |
Neoleukin Therapeutics, Inc. |
15 Aug 2023 |
12 |
+$1,463,487 |
4 |
Director, 10%+ Owner |
17 Aug 2023, 18:08 |
| KOD |
Kodiak Sciences Inc. |
30 Jun 2023 |
2 |
$0 |
4 |
Director, 10%+ Owner |
05 Jul 2023, 17:07 |
| IGMS |
IGM Biosciences, Inc. |
30 Jun 2023 |
2 |
$0 |
4 |
Director |
05 Jul 2023, 17:05 |
| INCY |
INCYTE CORP |
30 Jun 2023 |
2 |
$0 |
4 |
Director, 10%+ Owner |
05 Jul 2023, 17:04 |
| IGMS |
IGM Biosciences, Inc. |
26 Jun 2023 |
2 |
+$45,000,000 |
4 |
Director |
28 Jun 2023, 17:00 |
| PRLD |
Prelude Therapeutics Inc |
16 Jun 2023 |
2 |
$0 |
4 |
Director, 10%+ Owner |
21 Jun 2023, 16:47 |
| ONC |
BeiGene, Ltd. |
15 Jun 2023 |
4 |
$0 |
4 |
Director, 10%+ Owner |
20 Jun 2023, 17:34 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
15 Jun 2023 |
2 |
$0 |
4 |
Director |
20 Jun 2023, 16:10 |
| MDGL |
MADRIGAL PHARMACEUTICALS, INC. |
15 Jun 2023 |
0 |
$0 |
3 |
Director |
20 Jun 2023, 06:17 |
| INCY |
INCYTE CORP |
14 Jun 2023 |
4 |
$0 |
4 |
Director, 10%+ Owner |
16 Jun 2023, 16:02 |
| TCRX |
TScan Therapeutics, Inc. |
13 Jun 2023 |
2 |
$0 |
4 |
Director |
15 Jun 2023, 16:40 |
| /report/000120919123036773-baker-bros-advisors-lp-2023-06-09 |
Talis Biomedical Corp |
09 Jun 2023 |
2 |
$0 |
4 |
Director, 10%+ Owner |
13 Jun 2023, 16:52 |
| NGNE |
Neoleukin Therapeutics, Inc. |
08 Jun 2023 |
2 |
$0 |
4 |
Director |
12 Jun 2023, 16:03 |
| KNSA |
Kiniksa Pharmaceuticals, Ltd. |
06 Jun 2023 |
4 |
$0 |
4 |
Director |
08 Jun 2023, 17:37 |
| ACAD |
ACADIA PHARMACEUTICALS INC |
01 Jun 2023 |
3 |
$0 |
4 |
Director, 10%+ Owner |
05 Jun 2023, 17:14 |
| TCRX |
TScan Therapeutics, Inc. |
01 Jun 2023 |
2 |
+$74,996,250 |
4 |
Director |
02 Jun 2023, 16:00 |
| /report/000120919123034102-baker-bros-advisors-lp-2023-05-31 |
Seagen Inc. |
31 May 2023 |
2 |
$0 |
4 |
Director, 10%+ Owner |
02 Jun 2023, 21:30 |
| ACAD |
ACADIA PHARMACEUTICALS INC |
22 May 2023 |
18 |
+$23,132,348 |
4 |
Director, 10%+ Owner |
24 May 2023, 17:09 |
| PRLD |
Prelude Therapeutics Inc |
22 May 2023 |
4 |
+$74,998,839 |
4 |
Director, 10%+ Owner |
24 May 2023, 16:12 |
| /report/000120919123027629-baker-bros-advisors-lp-2023-05-05 |
BELLICUM PHARMACEUTICALS, INC |
05 May 2023 |
0 |
$0 |
3 |
10%+ Owner |
05 May 2023, 16:03 |
| /report/000120919123026917-baker-bros-advisors-lp-2023-05-01 |
Seagen Inc. |
01 May 2023 |
9 |
+$642,250 |
4 |
Director, 10%+ Owner |
03 May 2023, 16:04 |
| IGMS |
IGM Biosciences, Inc. |
04 Apr 2023 |
1 |
$0 |
4 |
Director, 10%+ Owner |
06 Apr 2023, 16:00 |
| INCY |
INCYTE CORP |
31 Mar 2023 |
2 |
$0 |
4 |
Director, 10%+ Owner |
04 Apr 2023, 15:59 |
| IGMS |
IGM Biosciences, Inc. |
31 Mar 2023 |
2 |
$0 |
4 |
Director, 10%+ Owner |
04 Apr 2023, 15:57 |
| INCY |
INCYTE CORP |
13 Mar 2023 |
4 |
+$909,600 |
4 |
Director, 10%+ Owner |
15 Mar 2023, 16:03 |
| ACAD |
ACADIA PHARMACEUTICALS INC |
12 Jan 2023 |
4 |
+$156,600 |
4 |
Director, 10%+ Owner |
17 Jan 2023, 15:22 |
| INCY |
INCYTE CORP |
30 Dec 2022 |
2 |
$0 |
4 |
Director, 10%+ Owner |
04 Jan 2023, 15:02 |
| INCY |
INCYTE CORP |
30 Sep 2022 |
2 |
$0 |
4 |
Director, 10%+ Owner |
04 Oct 2022, 16:18 |
| KOD |
Kodiak Sciences Inc. |
30 Jun 2022 |
1 |
$0 |
4 |
Director, 10%+ Owner |
05 Jul 2022, 16:26 |
| INCY |
INCYTE CORP |
30 Jun 2022 |
2 |
$0 |
4 |
Director, 10%+ Owner |
01 Jul 2022, 16:29 |
| KNSA |
Kiniksa Pharmaceuticals, Ltd. |
29 Jun 2022 |
3 |
$0 |
4 |
Director |
30 Jun 2022, 16:00 |
| ONC |
BeiGene, Ltd. |
22 Jun 2022 |
3 |
$0 |
4 |
Director, 10%+ Owner |
24 Jun 2022, 16:46 |
| PRLD |
Prelude Therapeutics Inc |
17 Jun 2022 |
1 |
$0 |
4 |
Director, 10%+ Owner |
22 Jun 2022, 16:06 |
| INCY |
INCYTE CORP |
15 Jun 2022 |
3 |
$0 |
4 |
Director, 10%+ Owner |
17 Jun 2022, 16:53 |
| DBVT |
DBV Technologies S.A. |
13 Jun 2022 |
4 |
$0 |
4 |
Director, 10%+ Owner |
13 Jun 2022, 17:27 |
| /report/000120919122036415-baker-bros-advisors-lp-2022-06-10 |
Talis Biomedical Corp |
10 Jun 2022 |
1 |
$0 |
4 |
Director, 10%+ Owner |
13 Jun 2022, 17:29 |
| ACAD |
ACADIA PHARMACEUTICALS INC |
07 Jun 2022 |
3 |
$0 |
4 |
Director, 10%+ Owner |
09 Jun 2022, 17:24 |
| KOD |
Kodiak Sciences Inc. |
02 Jun 2022 |
12 |
+$4,448,168 |
4 |
Director, 10%+ Owner |
06 Jun 2022, 17:08 |
| TRDA |
Entrada Therapeutics, Inc. |
02 Jun 2022 |
6 |
+$260,760 |
4 |
10%+ Owner |
06 Jun 2022, 17:07 |
| TCRX |
TScan Therapeutics, Inc. |
01 Jun 2022 |
1 |
$0 |
4 |
Director, 10%+ Owner |
03 Jun 2022, 16:40 |
| KOD |
Kodiak Sciences Inc. |
25 May 2022 |
16 |
+$2,363,748 |
4 |
Director, 10%+ Owner |
27 May 2022, 16:44 |
| TRDA |
Entrada Therapeutics, Inc. |
20 May 2022 |
10 |
+$282,447 |
4 |
10%+ Owner |
24 May 2022, 18:39 |
| TRDA |
Entrada Therapeutics, Inc. |
16 May 2022 |
8 |
+$430,701 |
4 |
10%+ Owner |
18 May 2022, 17:38 |
| KOD |
Kodiak Sciences Inc. |
16 May 2022 |
14 |
+$2,696,829 |
4 |
Director, 10%+ Owner |
18 May 2022, 17:30 |
| /report/000120919122029574-baker-bros-advisors-lp-2022-05-13 |
Seagen Inc. |
13 May 2022 |
3 |
$0 |
4 |
Director, 10%+ Owner |
17 May 2022, 16:02 |
| NGNE |
Neoleukin Therapeutics, Inc. |
12 May 2022 |
1 |
$0 |
4 |
Director |
16 May 2022, 16:01 |
| TCRX |
TScan Therapeutics, Inc. |
10 May 2022 |
8 |
+$2,559,154 |
4 |
Director, 10%+ Owner |
12 May 2022, 16:41 |
| IGMS |
IGM Biosciences, Inc. |
01 Apr 2022 |
2 |
+$65,000,001 |
4 |
Director, 10%+ Owner |
05 Apr 2022, 16:32 |
| INCY |
INCYTE CORP |
31 Mar 2022 |
2 |
$0 |
4 |
Director, 10%+ Owner |
04 Apr 2022, 16:54 |
| IGMS |
IGM Biosciences, Inc. |
12 Mar 2022 |
1 |
$0 |
4 |
Director, 10%+ Owner |
15 Mar 2022, 17:11 |
| INCY |
INCYTE CORP |
08 Mar 2022 |
14 |
+$28,989,770 |
4 |
Director, 10%+ Owner |
10 Mar 2022, 17:02 |
| /report/000120919122017900-baker-bros-advisors-lp-2022-03-08 |
Seagen Inc. |
08 Mar 2022 |
4 |
+$702,100 |
4 |
Director, 10%+ Owner |
10 Mar 2022, 15:39 |
| INCY |
INCYTE CORP |
17 Feb 2022 |
8 |
+$35,734,890 |
4 |
Director, 10%+ Owner |
22 Feb 2022, 16:45 |
| KOD |
Kodiak Sciences Inc. |
15 Feb 2022 |
10 |
+$21,832,153 |
4 |
Director, 10%+ Owner |
17 Feb 2022, 16:33 |
| INCY |
INCYTE CORP |
10 Feb 2022 |
7 |
+$106,952,404 |
4 |
Director, 10%+ Owner |
14 Feb 2022, 16:23 |
| KOD |
Kodiak Sciences Inc. |
27 Jan 2022 |
12 |
+$18,084,687 |
4 |
Director, 10%+ Owner |
31 Jan 2022, 16:06 |
| KOD |
Kodiak Sciences Inc. |
21 Jan 2022 |
10 |
+$28,806,796 |
4 |
Director, 10%+ Owner |
25 Jan 2022, 16:40 |
| INCY |
INCYTE CORP |
31 Dec 2021 |
2 |
$0 |
4 |
Director, 10%+ Owner |
04 Jan 2022, 15:16 |
| INCY |
INCYTE CORP |
15 Dec 2021 |
10 |
+$115,558,900 |
4 |
Director, 10%+ Owner |
17 Dec 2021, 17:30 |
| TRDA |
Entrada Therapeutics, Inc. |
14 Dec 2021 |
0 |
$0 |
3 |
10%+ Owner |
16 Dec 2021, 17:35 |
| /report/000141588921005643-baker-bros-advisors-lp-2021-11-30 |
Seagen Inc. |
30 Nov 2021 |
20 |
-$63,396,391 |
4 |
Director, 10%+ Owner |
02 Dec 2021, 17:51 |
| /report/000141588921005314-baker-bros-advisors-lp-2021-11-18 |
Talis Biomedical Corp |
18 Nov 2021 |
1 |
+$218,250 |
4 |
Director, 10%+ Owner |
19 Nov 2021, 15:09 |
| INCY |
INCYTE CORP |
30 Sep 2021 |
2 |
$0 |
4 |
Director, 10%+ Owner |
04 Oct 2021, 16:01 |
| KOD |
Kodiak Sciences Inc. |
29 Sep 2021 |
7 |
+$8,330,440 |
4 |
Director, 10%+ Owner |
01 Oct 2021, 16:58 |
| KOD |
Kodiak Sciences Inc. |
15 Sep 2021 |
3 |
+$3,005,281 |
4 |
Director, 10%+ Owner |
17 Sep 2021, 18:05 |
| KOD |
Kodiak Sciences Inc. |
07 Sep 2021 |
2 |
+$5,365,227 |
4 |
Director, 10%+ Owner |
09 Sep 2021, 18:43 |
| KOD |
Kodiak Sciences Inc. |
17 Aug 2021 |
10 |
+$10,009,957 |
4 |
Director, 10%+ Owner |
19 Aug 2021, 17:12 |
| KOD |
Kodiak Sciences Inc. |
11 Aug 2021 |
10 |
+$8,960,623 |
4 |
Director, 10%+ Owner |
13 Aug 2021, 19:14 |
| TCRX |
TScan Therapeutics, Inc. |
20 Jul 2021 |
6 |
+$21,375,000 |
4 |
Director |
22 Jul 2021, 16:06 |
| TCRX |
TScan Therapeutics, Inc. |
15 Jul 2021 |
0 |
$0 |
3 |
Director, 10%+ Owner |
15 Jul 2021, 18:10 |
| INCY |
INCYTE CORP |
30 Jun 2021 |
2 |
$0 |
4 |
Director, 10%+ Owner |
02 Jul 2021, 16:04 |
| KNSA |
Kiniksa Pharmaceuticals, Ltd. |
29 Jun 2021 |
1 |
$0 |
4 |
Director |
01 Jul 2021, 16:08 |
| KOD |
Kodiak Sciences Inc. |
28 Jun 2021 |
14 |
+$23,656,430 |
4 |
Director, 10%+ Owner |
30 Jun 2021, 19:29 |
| ACAD |
ACADIA PHARMACEUTICALS INC |
22 Jun 2021 |
3 |
$0 |
4 |
Director, 10%+ Owner |
24 Jun 2021, 16:22 |
| PRLD |
Prelude Therapeutics Inc |
18 Jun 2021 |
1 |
$0 |
4 |
Director, 10%+ Owner |
22 Jun 2021, 17:03 |
| ONC |
BeiGene, Ltd. |
16 Jun 2021 |
3 |
$0 |
4 |
Director, 10%+ Owner |
21 Jun 2021, 16:12 |
| SYRE |
Aeglea BioTherapeutics, Inc. |
08 Jun 2021 |
1 |
$0 |
4 |
Director |
10 Jun 2021, 16:31 |
| INCY |
INCYTE CORP |
26 May 2021 |
3 |
$0 |
4 |
Director, 10%+ Owner |
28 May 2021, 16:17 |
| INCY |
INCYTE CORP |
14 May 2021 |
4 |
+$758,800 |
4 |
Director, 10%+ Owner |
18 May 2021, 16:25 |
| /report/000163859921000465-baker-bros-advisors-lp-2021-05-14 |
Seagen Inc. |
14 May 2021 |
7 |
+$665,700 |
4 |
Director, 10%+ Owner |
18 May 2021, 16:23 |
| NGNE |
Neoleukin Therapeutics, Inc. |
11 May 2021 |
1 |
$0 |
4 |
Director |
13 May 2021, 17:23 |